Cyber Resilience

CVE-2023-38956

High

Published: 03 August 2023

Published
03 August 2023
Modified
21 November 2024
KEV Added
—
Patch
—
CVSS Score v3.1 7.5 CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:H/I:N/A:N
EPSS Score 0.0043 63.0th percentile
Risk Priority 15 60% EPSS · 20% KEV · 20% CVSS

Summary

CVE-2023-38956 is a high-severity Path Traversal (CWE-22) vulnerability in Zkteco Bioaccess Ivs. Its CVSS base score is 7.5 (High).

Operationally, ranked in the top 37.0% of CVEs by exploit likelihood; it is not currently listed in the CISA KEV catalog.

EU & UK References

Vulnerability details

A path traversal vulnerability in ZKTeco BioAccess IVS v3.3.1 allows unauthenticated attackers to read arbitrary files via supplying a crafted payload.

CWE(s)
CWE-22

Related Threats

No named actor attribution yet. ATT&CK technique mapping in progress for this CVE.

Affected Assets

zkteco
bioaccess ivs
3.3.1

Mitigating Controls

Likely Mitigating Controls AI

Per-CVE control mapping for this CVE has not run yet; the list below is derived from the weakness types (CWEs) cited in the NVD entry.

SI-10 Information Input Validation
addresses: CWE-22

Validates pathnames and filenames to prevent traversal outside intended directories.

References